Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
PDGFB quantification is a useful tool in the diagnosis of dermatofibrosarcoma protuberans: a study of 10 cases
Clinical and Experimental Dermatology, 09/10/09
Muchemwa FC et al. – Detection of the COL1A1/PDGFB fusion transcript may be important for the diagnosis of DFSP. Furthermore, relative PDGFB gene quantification by real–time PCR may also provide a good diagnostic tool when other methods fail to give conclusive results.
Related Articles
Intracranial infiltration by recurrent scalp dermatofibrosarcoma protuberans
Journal of Clinical Neuroscience, 10/07/09
Relevance Score: 67%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
PLX4032, a selective BRAFV600E kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAFWT melanoma cells
Pigment Cell & Melanoma Research, 03/17/10
Mutations in EDARADD account for a small proportion of hypohidrotic ectodermal dysplasia cases
British Journal of Dermatology, 03/16/10
Candidate gene study of susceptibility to cutaneous leishmaniasis in Sri Lanka
Tropical Medicine & International Health, 03/15/10
Today in Dermatologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Adnexal tumours of the skin as markers of cancer-prone syndromes
Journal of the European Academy of Dermatology and Venereology, 03/17/10
PLX4032, a selective BRAFV600E kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAFWT melanoma cells
Pigment Cell & Melanoma Research, 03/17/10
Multivariate evaluation of pharmacological responses in early clinical trials – a study of rIL-21 in the treatment of patients with metastatic melanoma
British Journal of Clinical Pharmacology, 03/16/10
Article Search
Sponsor
Sponsor


See Latest Articles


